Strides Arcolab rose 4.11% to Rs 143.10 at 11:44 IST on BSE after company said its board will meet on 22 July 2008 to consider a proposal to merge its subsidiaries Grandix Pharmaceuticals, Grandix Laboratories and Global Remedies with the company.
The stock hit a high of Rs 149.10 and a low of Rs 135.60 so far during the day. The stock had a 52-week high of Rs 328 on 12 December 2007 and a 52-week low of Rs 112 on 4 July 2008.
The pharma firm will announce its Q1 June 2008 result on 22 July 2008.
Strides Arcolab reported a net loss of Rs 16.05 crore in Q1 March 2008 as compared to net profit of Rs 7.76 crore in Q1 March 2007. Net sales rose 12.8% to Rs 119.69 crore in Q1 March 2008 over Q1 March 2007.
The company manufactures ethical pharmaceutical products, over the counter (OTC) products and nutraceuticals. It performs its activities through two segments, pharma and contract research and manufacturing (CRAM).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment